Lesch-Nyhan syndrome (Q40106): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
A síndrome de Lesch-Nyhan (LNS) é a forma mais grave de deficiência de hipoxantina-guanina fosforibosiltransferase (HPRT), um distúrbio hereditário do metabolismo das purinas e está associada a um aumento da produção de ácido úrico (SAU), problemas neurológicos e problemas comportamentais. Os pacientes são normais ao nascer. O atraso psicomotor torna-se evidente dentro de 3 a 6 meses, com atraso no apoio da cabeça e na posição sentada, hipotonia e atetose (movimentos involuntários, lentos, contínuos e contorcidos.). Deposição de urina arenosa nas fraldas ou cristalúria com obstrução do trato urinário são formas comuns de apresentação. Os pacientes geralmente apresentam deficiência intelectual leve a moderada. Suspeita-se da doença quando ocorre atraso psicomotor em um paciente com AU elevada no sangue e na urina. A atividade indetectável da enzima HPRT no sangue periférico ou em células intactas (eritrócitos, fibroblastos) e os testes de genética molecular confirmam o diagnóstico. A herança é recessiva ligada ao X.
description / endescription / en
 
Lesch-Nyhan syndrome (LNS) is the most severe form of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency, a hereditary disorder of purine metabolism, and is associated with uric acid overproduction (UAO), neurological troubles, and behavioural problems. Patients are normal at birth. Psychomotor delay becomes evident within 3 to 6 months with a delay in head support and sitting, hypotonia and athetoid movements. Sandy urine in diapers or crystalluria with urinary tract obstruction are common forms of presentation. Patients usually show mild to moderate intellectual deficit. Diagnosis is suspected when psychomotor delay occurs in a patient with elevated UA in blood and urine. Undetectable HPRT enzyme activity in peripheral blood or in intact cells (erythrocyte, fibroblast) and molecular genetic testing confirm the diagnosis. Inheritance is X-linked recessive.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1886495906 / rank
 
Normal rank
Property / CURIE
 
CID11:5C55.01
Property / CURIE: CID11:5C55.01 / rank
 
Normal rank
Property / Canary Token
 
dki-india-5C55.01
Property / Canary Token: dki-india-5C55.01 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: E79.1 / rank
 
Normal rank

Latest revision as of 05:47, 13 August 2026

Lesch-Nyhan syndrome (LNS) is the most severe form of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency, a hereditary disorder of purine metabolism, and is associated with uric acid overproduction (UAO), neurological troubles, and behavioural problems. Patients are normal at birth. Psychomotor delay becomes evident within 3 to 6 months with a delay in head support and sitting, hypotonia and athetoid movements. Sandy urine in diapers or crystalluria with urinary tract obstruction are common forms of presentation. Patients usually show mild to moderate intellectual deficit. Diagnosis is suspected when psychomotor delay occurs in a patient with elevated UA in blood and urine. Undetectable HPRT enzyme activity in peripheral blood or in intact cells (erythrocyte, fibroblast) and molecular genetic testing confirm the diagnosis. Inheritance is X-linked recessive.
Language Label Description Also known as
default for all languages
5C55.01
    English
    Lesch-Nyhan syndrome
    Lesch-Nyhan syndrome (LNS) is the most severe form of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency, a hereditary disorder of purine metabolism, and is associated with uric acid overproduction (UAO), neurological troubles, and behavioural problems. Patients are normal at birth. Psychomotor delay becomes evident within 3 to 6 months with a delay in head support and sitting, hypotonia and athetoid movements. Sandy urine in diapers or crystalluria with urinary tract obstruction are common forms of presentation. Patients usually show mild to moderate intellectual deficit. Diagnosis is suspected when psychomotor delay occurs in a patient with elevated UA in blood and urine. Undetectable HPRT enzyme activity in peripheral blood or in intact cells (erythrocyte, fibroblast) and molecular genetic testing confirm the diagnosis. Inheritance is X-linked recessive.

      Statements

      CID11:5C55.01
      0 references
      dki-india-5C55.01
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references